Dow Jones

40 700,15

1,21%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/08/2011	22h00	Business Wire	Allos Therapeutics Reports Second Quarter 2011 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/08/2011	23h25	Dow Jones News	2nd UPDATE: AMAG Pharma Gets Offer From Fund Opposing Allos Deal	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/07/2011	22h32	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/07/2011	17h15	Zacks	AMAG Trims Loss, Sales Remain Weak - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/07/2011	14h55	Zacks	Celgene Tops, Lifts View - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/07/2011	14h00	Business Wire	Allos Therapeutics to Report Second Quarter 2011 Results on August 4, 2011	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/07/2011	18h21	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/07/2011	12h02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/07/2011	00h39	Business Wire	The Law Firm of Weiss & Lurie Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	23h25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	22h05	Business Wire	Law Offices of Howard G. Smith Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	21h37	Business Wire	Bull & Lifshitz, LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	16h01	Business Wire	Goldfarb Branham Law Firm LLP Investigates Allos Therapeutics Inc Company	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	14h00	Zacks	AMAG to Merge with Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	03h55	Business Wire	MURRAY FRANK LLP Investigates Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	03h40	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2011	02h21	Business Wire	Robbins Umeda LLP Announces an Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	22h05	Business Wire	Law Office of Brodsky & Smith, LLC Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	18h39	Business Wire	The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	18h16	Business Wire	Harwood Feffer LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	16h37	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	16h37	Business Wire	Kendall Law Group Investigates Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	13h00	Business Wire	AMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost Synergies	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/07/2011	22h21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/06/2011	15h30	Zacks	Label Expansion for CELG's Istodax - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	23h29	Business Wire	Data Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	15h00	Marketwired	Research Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for Growth	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	12h50	GlobeNewswire Inc.	Allos Therapeutics is MicroStockProfit.com's Biopharm Feature Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	08h30	Business Wire	Data Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/06/2011	08h30	Business Wire	COMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)